Residual Insulin Secretion in Patients With Type 1 Diabetes Under a Low Carbohydrate Diet or a Ketogenic Diet (KetoDiab)
Sponsor: Assistance Publique - Hôpitaux de Paris
Listed as NCT05536232, this NA trial focuses on Type1 Diabetes and remains ongoing. Sponsored by Assistance Publique - Hôpitaux de Paris, it has been updated 6 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Oct 2024 — Present [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Sep 2024 — Oct 2024 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Feb 2023 — Jul 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Nov 2022 — Feb 2023 [monthly]
Not Yet Recruiting NA
▶ Show 1 earlier version
-
Sep 2022 — Nov 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Assistance Publique - Hôpitaux de Paris
For direct contact, visit the study record on ClinicalTrials.gov .